Abstract:Background: Autophagy, one of protein degradation system, contributes to maintain cellular homeostasis.Dysfunction of autophagy is associated with the development and progression of various liver diseases including nonalcoholic fatty liver disease (NAFLD) and hepatic cancer.Nuclear matrix protein (NMP) has been demonstrated to participate in many cellular functions.Changes in nuclear matrix structures result in alteration of DNA topology and the interaction of various genes with the matrix.The search for specific NMP modifications in tumors is available for diagnostic or prognostic markers for cancer.Here, we performed proteomic analysis of NMP to identify the novel autophagy-related diagnostic biomarker for NAFLD.Method: Insoluble nuclear protein fraction was extracted from the liver of Atg7 F/ F (wild type), Atg7 F/F :alb-Cre (Atg7 KO), C57BL/6J (control) and KKA y mice (NAFLD model).Proteins were separated with two-dimensional electrophoresis and visualized by silver stain.Protein spots were identified by mass spectrometry.Localization of identified proteins in a cell was verified by immunofluorescence using laser-scanning confocal microscope.Western blot analysis was performed to detect NMPs in serum.Localization of importin a4 and b1 in hepatocytes transfected with GFP-importin a4 or b1 plasmid was evaluated by laserscanning confocal microscope.Result: Twelve nuclear insoluble proteins up-regulated in both autophagy-deficient and NAFLD mice liver were identified.14-3-3 z, importin a4 and b1 were expressed in NMP and localized to nucleus in hepatocytes from both Atg7 KO and KKA y mice, in wild type and control mice, these NMPs were distributed into cytoplasm.14-3-3z, importin a4 and b1 were detectable in serum, and expressed in serum from autophagy-deficient mice and NAFLD model higher than wild type and control mice.Treatment with mTOR inhibitor rapamycin down-regulated the accumulation of 14-3-3 z in NMPs from KKA y mice.Importin a4 and b1 was translocated into nucleus by incubation with tunicamycin or H 2 O 2 for 12 hours.Conclusion: These results suggest that loss of autophagy alters expression of several nuclear proteins.Three autophagy-related NMP 14-3-3z, importin a4 and b1 were up-regulated in NAFLD model and detected in serum.Accumulation of 14-3-3z in NMPs is suggested to be associated with activation of mTOR.Increases in importin a4 and b1 in these NMPs indicate ER stress and oxidative stress.Evaluation of serum level of these NMPs may be useful tool for diagnosis of NAFLD with autophagy dysfunction.

Identification of MAP3K4 as a novel regulation factor of hepatic lipid metabolism in non-alcoholic fatty liver disease

Aberrant Hepatic Microrna Expression in Nonalcoholic Fatty Liver Disease

Expressions of Key Regulatory Genes of the Lipid Metabolism in Livers During the Development of Rat Non-alcoholic Fatty Liver Disease

Identification and immunological characterization of lipid metabolism-related molecular clusters in nonalcoholic fatty liver disease

Sa1668 Proteomic Analysis of Nonalcoholic Fatty Liver Disease: Attenuation of Coactosin-like Protein-1 Protects Liver from Steatosis and Injury

Long Non-Coding Rna Profiling In A Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight Into Pathogenesis

Sa1667 Hepatic-Specific Activation of Peroxisome Proliferator-Activated Receptor Y Coactivator-1α Protected Against Steatohepatitis

SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease

Sa1666 IGFBP1 Decreases Free Fatty Acid-Induced Hepatocyte Steatosis through Phosphorylation of FAK

MAPK1/3 regulate hepatic lipid metabolism via ATG7-dependent autophagy.

Identification of gene expression patterns in rat model of nonalcoholic fatty liver disease

LncNONMMUG027912 alleviates lipid accumulation through AMPKα/mTOR/SREBP1C axis in nonalcoholic fatty liver

Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease

NME4 mediates metabolic reprogramming and promotes nonalcoholic fatty liver disease progression

MicroRNAs As Biomarkers and Regulators of Nonalcoholic Fatty Liver Disease

Identification of human long noncoding RNAs associated with nonalcoholic fatty liver disease and metabolic homeostasis

A Network-Based Approach Reveals the Dysregulated Transcriptional Regulation in Non-Alcohol Fatty Liver Disease

Identification of key modules and driving genes in nonalcoholic fatty liver disease by weighted gene co-expression network analysis

Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLD

Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease

Removal of epigenetic repressive mark on inflammatory genes in fat liver